Aberdeen Diversified Income and Growth Trust (ADIG) invests globally using a flexible multi-asset approach via quoted and unquoted investments. It aims to generate attractive long-term capital and income returns by applying a diversified multi-asset approach, using quoted and unquoted investments, with no geographical or sector restrictions. This is a new investment objective which was approved by shareholders at the AGM in February 2021.
Investment Companies |
Review
Investment Companies |
Review
Investment Companies |
Update
Investment Companies |
Update
% | 1M | 3M | 12M |
---|---|---|---|
Actual | 0.0 | (2.0) | (1.1) |
Relative | (1.8) | (1.3) | (1.0) |
52 week high/low | 103.5p/95.0p |
Edison Investment Research is terminating coverage on Steakholder Foods (formerly known as MeaTech) (MITC), Mesoblast (MSB), Bluglass (BLG), InMed Pharmaceuticals (INM), Onxeo (ONXEO), Arcane Crypto (ARCANE) and Aberdeen Diversified Income and Growth Trust (ADIG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.